Latest Breaking News On - Phase 2 3 imerge mds3001 trial nct02598661 - Page 1 : comparemela.com

Sunil Iyer, MD, expands on the potential role of imetelstat for select patients with lower-risk myelodysplastic syndrome.

New yorkUnited statesSunil iyerOncologic drugs advisory committeeMeeting of the oncologic drugs advisory committeeColumbia university irving medical centerInternational prognostic scoring systemDrugs advisory committeeScience summitNew york cityLower risk myelodysplastic syndromePhase 2 3 imerge mds3001 trial nct02598661